Literature DB >> 1463594

MRI white matter hyperintensity in neuroleptic malignant syndrome (NMS)--a clue to pathogenesis?

T Becker1, J Kornhuber, E Hofmann, M Weller, C Rupprecht, H Beckmann.   

Abstract

The case of a young female patient with neuroleptic malignant syndrome (NMS) and extended MRI white matter hyperintensity in the left parietal and both occipital lobes is reported. MRI lesions resembled findings in hypertensive encephalopathy, they were not readily compatible with CNS vasculitis. Venous sinus thrombosis could be ruled out. Vascular encephalopathy with transient white matter edema and a small residual left parietal lesion is suggested. Neurochemical implications are discussed with particular reference to a possible involvement of excitatory amino acids in NMS pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1463594     DOI: 10.1007/bf01250797

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  32 in total

1.  Clinicopathological study of neurological complications due to hypertensive disorders of pregnancy.

Authors:  A Richards; D Graham; R Bullock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-03       Impact factor: 10.154

2.  Magnetic resonance evaluation of severe neurological disorders in eclampsia.

Authors:  O Vandenplas; A Dive; G Dooms; P Mahieu
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

3.  Case report of neuroleptic malignant syndrome associated with withdrawal from amantadine.

Authors:  D M Simpson; G C Davis
Journal:  Am J Psychiatry       Date:  1984-06       Impact factor: 18.112

4.  Neuroleptic malignant syndrome: review and analysis of 115 cases.

Authors:  G Addonizio; V L Susman; S D Roth
Journal:  Biol Psychiatry       Date:  1987-08       Impact factor: 13.382

5.  Fluoxetine and neuroleptic malignant syndrome.

Authors:  M Halman; D S Goldbloom
Journal:  Biol Psychiatry       Date:  1990-09-15       Impact factor: 13.382

6.  Computerized tomographic appearance of hypertensive encephalopathy.

Authors:  D L Rail; G D Perkin
Journal:  Arch Neurol       Date:  1980-05

7.  A case of clozapine-induced neuroleptic malignant syndrome.

Authors:  D D Miller; M J Sharafuddin; R G Kathol
Journal:  J Clin Psychiatry       Date:  1991-03       Impact factor: 4.384

8.  Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia.

Authors:  A Kochhar; J A Zivin; P D Lyden; V Mazzarella
Journal:  Arch Neurol       Date:  1988-02

9.  Hypothalamic pathology in the neuroleptic malignant syndrome.

Authors:  E Horn; B Lach; Y Lapierre; P Hrdina
Journal:  Am J Psychiatry       Date:  1988-05       Impact factor: 18.112

Review 10.  Cerebellar degeneration in neuroleptic malignant syndrome: neuropathologic findings and review of the literature concerning heat-related nervous system injury.

Authors:  S Lee; A Merriam; T S Kim; M Liebling; D W Dickson; G R Moore
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-03       Impact factor: 10.154

View more
  1 in total

1.  Case reports of neuroleptic malignant syndrome in context of quetiapine use.

Authors:  Mark B Detweiler; Kelly Sullivan; Taral R Sharma; Kye Y Kim; Jonna G Detweiler
Journal:  Psychiatr Q       Date:  2013-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.